Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 1,658 | 55 | 0 | 0 |
| Revenue growth | 2914.5% | | | |
| Cost of goods sold | 4,781 | 520 | 0 | 0 |
| Gross profit | -3,123 | -465 | 0 | 0 |
| Gross margin | -188.4% | -845.5% | | |
| Selling, general and administrative | 1,789 | 1,242 | 255 | 108 |
| Research and development | 1,944 | 1,850 | 766 | 301 |
| EBIT | -6,856 | -4,220 | -1,021 | -409 |
| EBIT margin | -413.5% | -7672.7% | | |
| Pre-tax income | -6,748 | -4,688 | -1,018 | -426 |
| Income taxes | 4 | 0 | 0 | 0 |
| Tax rate | | 0.0% | 0.0% | 0.0% |
| Net income | -6,752 | -4,688 | -1,019 | -426 |
| Net margin | -407.2% | -8523.6% | | |
| |
| Diluted EPS | ($7.40) | ($22.98) | ($10.09) | ($4.35) |
| Shares outstanding (diluted) | 913 | 204 | 101 | 98 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|